Lp-PLA2 Activity in Metabolic Syndrome and Carotid Atherosclerosis
Author Information
Author(s): Gong Hui-ping, Du Yi-meng, Zhong Li-na, Dong Zhao-qiang, Wang Xin, Mao Yong-jun, Lu Qing-hua
Primary Institution: Second Hospital of Shandong University
Hypothesis
The study aimed to evaluate the potential role of Lp-PLA2 as a comprehensive marker of metabolic syndrome in individuals with and without carotid atherosclerosis.
Conclusion
Lp-PLA2 may be a modulating factor for carotid IMT via age and LDL-cholesterol, but is not an independent predictor in the pathophysiological process of carotid atherosclerosis in patients with MetS.
Supporting Evidence
- Lp-PLA2 activity was significantly increased in MetS subgroups compared to controls.
- Lp-PLA2 was higher in patients with carotid plaques than those without.
- Age, LDL-cholesterol, and waist-hip ratio were significant determinants of Lp-PLA2 activity.
Takeaway
This study looked at a protein called Lp-PLA2 in people with metabolic syndrome and found that it might help understand heart problems, but it doesn't directly cause them.
Methodology
The study involved measuring Lp-PLA2 activity in 118 patients with metabolic syndrome and 70 healthy controls, using ELISA and ultrasound for carotid IMT.
Limitations
The study relied on single measurements of Lp-PLA2, which may not reflect true activity over time, and the influence of medications on Lp-PLA2 activity could not be eliminated.
Participant Demographics
118 patients with metabolic syndrome (53 men, 65 women, aged 32-71) and 70 age- and sex-matched healthy controls.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website